Home
Browse
Search
Tools
Data
Help
Contact us
None
None
None
Abstract
Dose-dependent inhibition of SARS-CoV-2 3CL-Pro
DOI:
10.6019/EOS300041
Knowledge Graph
Similar Paper
None
None
nan
None
None
nan
None
None
nan
Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19
European Journal of Medicinal Chemistry
2022.0
None
None
nan
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
Bioorganic & Medicinal Chemistry Letters
2021.0
Discovery of Natural Bisbenzylisoquinoline Analogs from the Library of Thai Traditional Plants as SARS-CoV-2 3CL<sup>Pro</sup> Inhibitors: In Silico Molecular Docking, Molecular Dynamics, and In Vitro Enzymatic Activity
Journal of Chemical Information and Modeling
2023.0
Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
European Journal of Medicinal Chemistry
2023.0
None
None
nan
Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2
Journal of Medicinal Chemistry
2022.0